Laboratorio de Neurociencias
LABORATORIO DE NEUROCIENCIAS
![Foto de Laboratorio de Neurociencias](/img/uploaded/F882B7571FB7FA456A3DA4BE5247AE8F.png)
![Foto de Instituto de Salud Carlos III](/img/noimage_org.png)
Instituto de Salud Carlos III
Madrid, EspañaPublications en collaboration avec des chercheurs de Instituto de Salud Carlos III (9)
2022
2021
-
Hyperspectral image processing for the identification and quantification of lentiviral particles in fluid samples
Scientific Reports, Vol. 11, Núm. 1
2020
-
Parkin-mediated mitophagy and autophagy flux disruption in cellular models of MERRF syndrome
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 6
2019
-
ADCK2 haploinsufficiency reduces mitochondrial lipid oxidation and causes myopathy associated with CoQ deficiency
Journal of Clinical Medicine, Vol. 8, Núm. 9
-
Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome
Neurobiology of Disease, Vol. 125, pp. 92-106
-
Pantothenate Rescues Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration Depending on the Type of Mutation
Molecular Neurobiology, Vol. 56, Núm. 5, pp. 3638-3656
2014
-
Stabilization of apoptotic cells: Generation of zombie cells
Cell Death and Disease, Vol. 5, Núm. 8
2012
-
Involvement of cannabinoid CB1 receptor in associative learning and in hippocampal CA3-CA1 synaptic plasticity
Cerebral Cortex, Vol. 22, Núm. 3, pp. 550-566
2010
-
Associative learning and CA3-CA1 synaptic plasticity are impaired in D 1R null, Drd1a-/- mice and in hippocampal siRNA silenced Drd1a mice
Journal of Neuroscience, Vol. 30, Núm. 37, pp. 12288-12300